2023 May 04
Adding Epigenetic Drug to Standard Chemotherapy Was Effective in Pilot Study for T-cell Lymphoma
Nearly 90 percent of patients with an aggressive subtype of non-Hodgkin lymphoma had their cancer go into remission in a small phase 2 clinical trial testing a treatment aimed at making chemotherapy more effective, according... Read more